The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Immune Reconstitution in HIV‐Infected Patients
Open accessAbstract
The prognosis of patients infected with human immunodeficiency virus (HIV) type 1 has dramatically improved since the advent of potent antiretroviral therapies (ARTs), which have enabled sustained suppression of HIV replication and recovery of CD4 T cell counts. Knowledge of the function of CD4 T cells in immune reconstitution was derived from large clinical studies demonstrating that primary and secondary prophylaxis against infectious agents, such as Pneumocystis jirovecii (Pneumocystis carinii), Mycobacterium avium complex, cytomegalovirus, and other pathogens, can be discontinued safely once CD4 T cell counts have increased beyond pathogen-specific threshold levels (usually >200 CD4 T cells/mm3) for 3-6 months. The downside of immune reconstitution is an inflammatory syndrome occurring days to months after the start of ART, with outcomes ranging from minimal morbidity to fatal progression. This syndrome can be elicited by infectious and noninfectious antigens. Microbiologically, the possible pathogenic pathways involve recognition of antigens associated with ongoing infection or recognition of persisting antigens associated with past (nonreplicating) infection. Specific antimicrobial therapy, nonsteroidal anti-inflammatory drugs, and/or steroids for managing immune reconstitution syndrome should be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Autran, B., Carcelain, G., Li, T. S., Blanc, C., Mathez, D., Tubiana, R., Katlama, C., Debré, P., & Leibowitch, J. (1997) · Science · doi:10.1126/science.277.5322.112 · Cited by 1,785
Egger, M., May, M., Chêne, G., Phillips, A. N., Ledergerber, B., Dabis, F., Costagliola, D., Monforte, A. D., de Wolf, F., Reiss, P., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09411-4 · Cited by 1,525
Sulkowski, M. S. (2000) · JAMA · doi:10.1001/jama.283.1.74 · Cited by 950
Pakker, N. G., Notermans, D. W., De Boer, R. J., Roos, M. T. L., Wolf, F. D., Hill, A., Leonard, J. M., Danner, S. A., Miedema, F., & Schellekens, P. T. A. (1998) · Nature Medicine · doi:10.1038/nm0298-208 · Cited by 701
Hirsch, H. H., & Steiger, J. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00770-9 · Cited by 662
Self-citationEgger, M., Hirschel, B., Francioli, P., Sudre, P., Wirz, M., Flepp, M., Rickenbach, M., Malinverni, R., Vernazza, P., & Battegay, M. (1997) · BMJ · doi:10.1136/bmj.315.7117.1194 · Cited by 615
Self-citationParadoxical Worsening of Tuberculosis Following Antiretroviral Therapy in Patients with AIDS
NARITA, M., ASHKIN, D., HOLLENDER, E. S., & PITCHENIK, A. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.1.9712001 · Cited by 608
Masur, P. B. H., Kaplan, J. E., & Holmes, K. K. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_2-200209031-00002 · Cited by 567
HIV viral load markers in clinical practice
Saag, M. S., Holodniy, M., Kuritzkes, D. R., O'Brien, W. A., Coombs, R., Poscher, M. E., Jacobsen, D. M., Shaw, G. M., Richman, D. D., & Volberding, P. A. (1996) · Nature Medicine · doi:10.1038/nm0696-625 · Cited by 524
Dybul, M., Fauci, A. S., Bartlett, J. G., Kaplan, J. E., & Pau, A. K. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_2-200209031-00001 · Cited by 482
Ledergerber, B., Egger, M., Erard, V., Weber, R., Hirschel, B., Furrer, H., Battegay, M., Vernazza, P., Bernasconi, E., Opravil, M., et al. (1999) · JAMA · doi:10.1001/jama.282.23.2220 · Cited by 481
Self-citationFrench, M. A., Lenzo, N., John, M., Mallal, S. A., McKinnon, E. J., James, I. R., Price, P., Flexman, J. P., & Tay‐Kearney, M. (2000) · HIV Medicine · doi:10.1046/j.1468-1293.2000.00012.x · Cited by 413
Kaufmann, G. R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.18.2187 · Cited by 409
Self-citationDeSimone, J. A., Pomerantz, R. J., & Babinchak, T. J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-6-200009190-00013 · Cited by 383
Guidelines for preventing opportunistic infections among HIV-infected persons
Je, K. (2002) · Medical Entomology and Zoology · Cited by 355
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy
Martínez, E., Blanco, J. L., Arnaiz, J. A., Pérez-Cuevas, J. B., Mocroft, A., Cruceta, A., Marcos, M. A., Milinkovic, A., García-Viejo, M. A., Mallolas, J., et al. (2001) · AIDS · doi:10.1097/00002030-200107060-00007 · Cited by 349
HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus
Altfeld, M., Allen, T. M., Yu, X. G., Johnston, M. N., Agrawal, D., Korber, B. T., Montefiori, D. C., O'Connor, D. H., Davis, B. T., Lee, P. K., et al. (2002) · Nature · doi:10.1038/nature01200 · Cited by 304
John, M., Flexman, J., & French, M. A. H. (1998) · AIDS · doi:10.1097/00002030-199817000-00010 · Cited by 251
Furrer, H., Egger, M., Opravil, M., Bernasconi, E., Hirschel, B., Battegay, M., Telenti, A., Vernazza, P. L., Rickenbach, M., Flepp, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401701 · Cited by 249
Self-citationImmunopathogenesis and immunotherapy in AIDS virus infections
Letvin, N. L., & Walker, B. D. (2003) · Nature Medicine · doi:10.1038/nm0703-861 · Cited by 239
Weverling, G. J., Mocroft, A., Ledergerber, B., Kirk, O., Gonzales-Lahoz, J., Monforte, A. D., Proenca, R., Phillips, A. N., Lundgren, J. D., & Reiss, P. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03287-0 · Cited by 220
Immunorestitution Disease Involving the Innate and Adaptive Response
Cheng, V. C. C., Yuen, K.-Y., Chan, W.-M., Ma, E. S. K., & Chan, R. M. T. (2000) · Clinical Infectious Diseases · doi:10.1086/313809 · Cited by 214
de Quiros, J. C. L. B., Miro, J. M., Peña, J. M., Podzamczer, D., Alberdi, J. C., Martínez, E., Cosin, J., Claramonte, X., Gonzalez, J., Domingo, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101183440301 · Cited by 203
Jenny‐Avital, E. R., & Abadi, M. (2002) · Clinical Infectious Diseases · doi:10.1086/344467 · Cited by 185
Carr, A., & Cooper, D. A. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62892-9 · Cited by 169
Kaufmann, G. R., Bloch, M., Finlayson, R., Zaunders, J., Smith, D., & Cooper, D. A. (2002) · AIDS · doi:10.1097/00002030-200202150-00007 · Cited by 169
Self-citationLedergerber, B., Mocroft, A., Reiss, P., Furrer, H., Kirk, O., Bickel, M., Uberti-Foppa, C., Pradier, C., d'Arminio Monforte, A., Schneider, M. M. E., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101183440302 · Cited by 165
French, M. A. H., Mallal, S. A., & Dawkins, R. L. (1992) · AIDS · doi:10.1097/00002030-199211000-00009 · Cited by 161
Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy
Langford, T. D., Letendre, S. L., Marcotte, T. D., Ellis, R. J., McCutchan, J. A., Grant, I., Mallory, M. E., Hansen, L. A., Archibald, S., Jernigan, T., et al. (2002) · AIDS · doi:10.1097/00002030-200205030-00008 · Cited by 160
El‐Sadr, W., Burman, W. J., Grant, L. B., Matts, J. P., Hafner, R., Crane, L. R., Zeh, D., Gallagher, B., Mannheimer, S., Martínez, A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004133421503 · Cited by 150
Woods, M. L., MacGinley, R., Eisen, D. P., & Allworth, A. M. (1998) · AIDS · doi:10.1097/00002030-199812000-00011 · Cited by 150
Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients
Foudraine, N. A., Hovenkamp, E., Notermans, D. W., Meenhorst, P. L., Klein, M. R., Lange, J. M. A., Miedema, F. F., & Reiss, P. (1999) · AIDS · doi:10.1097/00002030-199902040-00005 · Cited by 136
Kirk, O., Reiss, P., Uberti‐Foppa, C., Bickel, M., Gerstoft, J., Pradier, C., Wit, F. W. N. M., Ledergerber, B., Lundgren, J. D., Furrer, H., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-4-200208200-00008 · Cited by 134
Vibhagool, A., D, S. S. M., Mootsikapun, P., Chetchotisakd, P., Tansuphaswaswadikul, S., Bowonwatanuwong, C., & Ingsathit, A. (2003) · Clinical Infectious Diseases · doi:10.1086/374849 · Cited by 127
Urrer, H. A. F., Gger, M. A. E., Pravil, M. I. O., Ernasconi, E. N. B., Irschel, B. E. H., Attegay, M. A. B., Elenti, A. M. T., Ietro, P., Ernazza, L. V., Ickenbach, M. A. R., et al. (1999) · Cited by 124
Pulmonary Tuberculosis in AIDS Patients
Fishman, J. E., Lavi, E. S., Narita, M., et al. (2000) · American Journal of Roentgenology · doi:10.2214/ajr.174.1.1740043 · Cited by 120
Savès, M., Raffi, F., Clevenbergh, P. A., Marchou, B., Waldner-Combernoux, A., Morlat, P., Moing, V. L., Rivière, C., Chêne, G., Leport, C., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3451-3455.2000 · Cited by 118
Law, W. P., Dore, G. J., Duncombe, C. J., Mahanontharit, A., Boyd, M. A., Ruxrungtham, K., Lange, J. M. A., Phanuphak, P., & Cooper, D. A. (2003) · AIDS · doi:10.1097/00002030-200310170-00007 · Cited by 116
Tarwater, P. M., Margolick, J. B., Jin, J., Phair, J. P., Detels, R., Rinaldo, C. R., Giorgi, J. V., & Muñoz, A. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200106010-00012 · Cited by 115
Crump, J. A., Tyrer, M., Lloyd‐Owen, S. J., Han, L. Y., Lipman, M. C. I., & Johnson, M. A. (1998) · Clinical Infectious Diseases · doi:10.1086/517636 · Cited by 113
Wendland, T., Furrer, H., Vernazza, P., Frutig, K., Christen, A., Matter, L., Malinverni, R., & Pichler, W. J. (1999) · AIDS · doi:10.1097/00002030-199910010-00007 · Cited by 111
Paradoxical Reactions in HIV and Pulmonary TB
Chien, J. W., & Johnson, J. L. (1998) · CHEST Journal · doi:10.1378/chest.114.3.933 · Cited by 102
Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy
Kaufmann, G. R., Bloch, M., Zaunders, J., Smith, D. E., & Cooper, D. A. (2000) · AIDS · doi:10.1097/00002030-200005260-00007 · Cited by 101
Self-citationKirk, O., Lundgren, J. D., Pedersen, C., et al. (1999) · AIDS · doi:10.1097/00002030-199909100-00007 · Cited by 99
Fox, P., Barton, S., Francis, N. D., Youle, M. S., Henderson, D. C., Pillay, D., Johnson, M., Fearfield, L. A., Gazzard, B. G., & Bunker, C. B. (1999) · HIV Medicine · doi:10.1046/j.1468-1293.1999.00003.x · Cited by 94
Clinical Indicators of Immune Restoration following Highly Active Antiretroviral Therapy
Cooney, E. L. (2002) · Clinical Infectious Diseases · doi:10.1086/323898 · Cited by 88
Hoff, J., Bani‐Sadr, F., Gassin, M., & Raffi, F. (2001) · Clinical Infectious Diseases · doi:10.1086/319368 · Cited by 88
Mycobacterial Lymphadenitis Associated With the Initiation of Combination Antiretroviral Therapy
Phillips, P., Kwiatkowski, M. B., Copland, M. A., Craib, K. J. P., & Montaner, J. S. G. (1999) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199902010-00003 · Cited by 83
Smith, C. J., Sabin, C. A., Lampe, F. C., Loes, S. K., Gumley, H., Carroll, A., Prinz, B., Youle, M. S., Johnson, M. A., & Phillips, A. N. (2003) · AIDS · doi:10.1097/00002030-200305020-00004 · Cited by 82
Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV‐infected subjects
Barry, S. M., Lipman, M. C. I., Deery, A., Johnson, M., & Janossy, G. (2002) · HIV Medicine · doi:10.1046/j.1468-1293.2002.00115.x · Cited by 78
Blanche, P. (1998) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365549850161223 · Cited by 71
Furrer, H., & Malinverni, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00015-7 · Cited by 70
King, M. D., Perlino, C. A., Cinnamon, J., & Jernigan, J. A. (2002) · International Journal of STD & AIDS · doi:10.1258/095646202760326516 · Cited by 69
Koval, C. E., Gigliotti, F., Nevins, D. L., & Demeter, L. M. (2002) · Clinical Infectious Diseases · doi:10.1086/341974 · Cited by 69
Mediastinitis Due to Cryptococcal Infection: A New Clinical Entity in the HAART Era
Trevenzoli, M., Cattelan, A. M., Rea, F., Sasset, L., Semisa, M., Lanzafame, M., Meneghetti, F., & Cadrobbi, P. (2002) · Journal of Infection · doi:10.1016/s0163-4453(02)91052-2 · Cited by 55
Nolan, R. C., Chidlow, G. R., & French, M. A. (2003) · Clinical Infectious Diseases · doi:10.1086/374603 · Cited by 52
Rambeloarisoa, J., Batisse, D., Thiébaut, J.-B., Mikol, J., Mrejen, S., Karmochkine, M., Kazatchkine, M. D., Weiss, L., & Piketty, C. (2002) · Journal of Infection · doi:10.1053/jinf.2001.0955 · Cited by 47
HIV1 and the gut in the era of highly active antiretroviral therapy
Nannini, E. C., & Okhuysen, P. C. (2002) · Current Gastroenterology Reports · doi:10.1007/s11894-002-0009-z · Cited by 47
Immune restoration disease in HIV patients: aberrant immune responses after antiretroviral therapy.
French, M. A., & Price, P. (2002) · UWA Profiles and Research Repository (UWA) · Cited by 12
Antiretroviral therapy: When and what to start—an American perspective
Wilkin, T. J., & Gulick, R. M. (2003) · Current Infectious Disease Reports · doi:10.1007/s11908-003-0012-z · Cited by 4
Management of opportunistic infection prophylaxis in the highly active antiretroviral therapy era
Furrer, H., & Study, S. H. C. (2002) · Current Infectious Disease Reports · doi:10.1007/s11908-002-0058-3 · Cited by 3
When to start antiretroviral therapy and what to start with—a European perspective
Wit, F. W. N. M., & Reiss, P. (2003) · Current Infectious Disease Reports · doi:10.1007/s11908-003-0013-y · Cited by 3
Cited by
Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection
Steigbigel, R. T., Cooper, D. A., Kumar, P. N., Eron, J. E., Schechter, M., Markowitz, M., Loutfy, M. R., Lennox, J. L., Gatell, J. M., Rockstroh, J. K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708975 · Cited by 691
Shelburne, S. A., Visnegarwala, F., Darcourt, J., Graviss, E. A., Giordano, T. P., White, A. C., & Hamill, R. J. (2005) · AIDS · doi:10.1097/01.aids.0000161769.06158.8a · Cited by 632
The 1918 Influenza Pandemic: Insights for the 21st Century
Morens, D. M., & Fauci, A. S. (2007) · The Journal of Infectious Diseases · doi:10.1086/511989 · Cited by 536
Shiohara, T., Inaoka, M., & Kano, Y. (2006) · Allergology International · doi:10.2332/allergolint.55.1 · Cited by 485
Histological Patterns of Polyomavirus Nephropathy: Correlation with Graft Outcome and Viral Load
Drachenberg, C. B., Papadimitriou, J. C., Hirsch, H. H., Wali, R., Crowder, C., Nogueira, J., Cangro, C. B., Mendley, S., Mian, A., & Ramos, E. (2004) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2004.00603.x · Cited by 406
Self-citation
Metadata
- Authors
- Hirsch, H. H., Kaufmann, G., Sendi, P., & Battegay, M.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-04-15
- Volume
- 38
- Issue
- 8
- Pages
- 1159-1166
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2171034892
- Cited by
- 327
- References
- 64
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.